Blueprint Medicines: Q2 Earnings Insights

Blueprint Medicines BPMC reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Blueprint Medicines missed estimated earnings by 20.18%, reporting an EPS of $-2.68 versus an estimate of $-2.23.

Revenue was up $9.25 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 0.7% increase in the share price the next day.

Here's a look at Blueprint Medicines's past performance:

To track all earnings releases for Blueprint Medicines visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.